Projects funded by the NCN

Natural and synthetic isothiocyanates as a compounds with potential anticancer activity

Call: PRELUDIUM 1 , Panel: NZ4

Principal investigator: Mateusz Psurski

Politechnika Wrocławska, Wydział Chemiczny

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Combined induction of cell death of canine leukemia and lymphoma.

Call: OPUS 2 , Panel: NZ5

Principal investigator: dr hab. Andrzej Rapak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

Call: OPUS 19 , Panel: NZ7

Principal investigator: dr hab. Janusz Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Call: OPUS 16 , Panel: NZ5

Principal investigator: dr hab. Ryszard Smolarczyk

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

System engineering approach to modeling, analysis and prediction of outcome of combined anticancer therapies

Call: OPUS 11 , Panel: ST7

Principal investigator: prof. Andrzej Świerniak

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

New, multifunctional nanoparticles for combined photothermal and gene silencing cancer therapy

Call: OPUS 11 , Panel: ST8

Principal investigator: prof. Stefan Jurga

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne